Cargando…
Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2)
Bariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≧ 35 kg/m(2). Mounting evidence also shows that metabolic surgery is effective for T2DM with BMI < 35 kg/m(2). To evaluate current status of metabolic surgery,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375149/ https://www.ncbi.nlm.nih.gov/pubmed/22720136 http://dx.doi.org/10.1155/2012/147256 |
_version_ | 1782235719196999680 |
---|---|
author | Shimizu, Hideharu Timratana, Poochong Schauer, Philip R. Rogula, Tomasz |
author_facet | Shimizu, Hideharu Timratana, Poochong Schauer, Philip R. Rogula, Tomasz |
author_sort | Shimizu, Hideharu |
collection | PubMed |
description | Bariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≧ 35 kg/m(2). Mounting evidence also shows that metabolic surgery is effective for T2DM with BMI < 35 kg/m(2). To evaluate current status of metabolic surgery, we reviewed the available clinical studies which described surgical treatment for T2DM with mean BMI < 35 kg/m(2). 18 studies with 477 patients were identified. 30% of the patients was insulin users. The follow-up period ranged from 6 to 216 months. The weight loss effect was reasonable, not excessive. Mean BMI decreased from 30.4 to 24.8 kg/m(2). Remission of T2DM was achieved in 64.7% of the patients with fasting plasma glucose and glycated hemoglobin approaching slightly above normal range. Clinical T2DM status was an important factor when selecting the eligible candidates for metabolic surgery. Postoperative complication rate of 10.3% with mortality of 0% in the studies has been acceptable. Even though it would be premature at this point to state that metabolic surgery is an accepted treatment option for T2DM with BMI < 35 kg/m(2), it is clear that a high proportion of T2DM patients will derive substantial benefit from metabolic surgery. |
format | Online Article Text |
id | pubmed-3375149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33751492012-06-20 Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) Shimizu, Hideharu Timratana, Poochong Schauer, Philip R. Rogula, Tomasz J Obes Review Article Bariatric/metabolic surgery is considered an accepted treatment option for type 2 diabetes mellitus (T2DM) with body mass index (BMI) ≧ 35 kg/m(2). Mounting evidence also shows that metabolic surgery is effective for T2DM with BMI < 35 kg/m(2). To evaluate current status of metabolic surgery, we reviewed the available clinical studies which described surgical treatment for T2DM with mean BMI < 35 kg/m(2). 18 studies with 477 patients were identified. 30% of the patients was insulin users. The follow-up period ranged from 6 to 216 months. The weight loss effect was reasonable, not excessive. Mean BMI decreased from 30.4 to 24.8 kg/m(2). Remission of T2DM was achieved in 64.7% of the patients with fasting plasma glucose and glycated hemoglobin approaching slightly above normal range. Clinical T2DM status was an important factor when selecting the eligible candidates for metabolic surgery. Postoperative complication rate of 10.3% with mortality of 0% in the studies has been acceptable. Even though it would be premature at this point to state that metabolic surgery is an accepted treatment option for T2DM with BMI < 35 kg/m(2), it is clear that a high proportion of T2DM patients will derive substantial benefit from metabolic surgery. Hindawi Publishing Corporation 2012 2012-06-05 /pmc/articles/PMC3375149/ /pubmed/22720136 http://dx.doi.org/10.1155/2012/147256 Text en Copyright © 2012 Hideharu Shimizu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Shimizu, Hideharu Timratana, Poochong Schauer, Philip R. Rogula, Tomasz Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) |
title | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) |
title_full | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) |
title_fullStr | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) |
title_full_unstemmed | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) |
title_short | Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2) |
title_sort | review of metabolic surgery for type 2 diabetes in patients with a bmi < 35 kg/m(2) |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375149/ https://www.ncbi.nlm.nih.gov/pubmed/22720136 http://dx.doi.org/10.1155/2012/147256 |
work_keys_str_mv | AT shimizuhideharu reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 AT timratanapoochong reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 AT schauerphilipr reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 AT rogulatomasz reviewofmetabolicsurgeryfortype2diabetesinpatientswithabmi35kgm2 |